SCHEMBL13630983

SCHEMBL13630983

CCc1ccc(C=O)cc1C#N

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
TSHR P16473 1/20 0.40
FDPS P14324 1/20 0.39
ALDH1A3 P47895 4/20 0.38
ALDH3A1 P30838 4/20 0.37
EGFR P00533 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
KDM4E B2RXH2 1/20 0.35
PTGS2 P35354 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP2A6 P11509 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13571237 0.85 ALDH1A1 (0.39) ALDH1A1TSHRFDPSALDH1A3ALDH3A1
SCHEMBL16956871 0.84 ALDH1A1 (0.34) ALDH1A1PDE3BPDE3AKDM4ETDP1
SCHEMBL15776741 0.84 FDPS (0.38) ALDH1A1FDPSPDE3BPDE3AKDM4E
SCHEMBL16952589 0.84 ALDH1A1 (0.34) ALDH1A1PDE3BPDE3AKDM4ETDP1
SCHEMBL21381231 0.84 EGFR (0.39) ALDH1A1TSHRFDPSEGFRPDE3B
SCHEMBL24821192 0.80 NLRP3 (0.40) ALDH1A1TSHRKDM4ERAB9AHSD17B10
SCHEMBL6899726 0.78 ALDH1A1 (0.47) ALDH1A1TSHRFDPSEGFRKDM4E
SCHEMBL13571069 0.77 ALDH1A1 (0.37) ALDH1A1TSHRFDPSALDH1A3ALDH3A1
SCHEMBL29956523 0.77 TSHR (0.43) ALDH1A1TSHRFDPSALDH1A3EGFR
SCHEMBL6435855 0.77 TSHR (0.43) ALDH1A1TSHRFDPSALDH1A3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615550-B2 Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists GLAXO GROUP LIMITED (GB) 2009-11-10 US disclosed